Genetic test to predict breast cancer recurrence and drug response

Author：

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.1, 2005-01, pp. : 5-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Genetic Instability Influences Drug Response in Cancer Cells

Current Drug Targets, Vol. 11, Iss. 10, 2010-10 ,pp. : 1317-1324

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomics to predict drug response

By Adam Gail IR Reneland Richard Andersson Maria Risinger Carl Nilsson Mats Lewander Tommy

Pharmacogenomics, Vol. 1, Iss. 1, 2000-02 ,pp. : 5-14

Future Medicine

Access to resources Recommend Favorite

Impact of metabolizing enzymes on drug response of endocrine therapy in breast cancer

By Saladores Pilar H Precht Jana C Schroth Werner Brauch Hiltrud Schwab Matthias

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 4, 2013-05 ,pp. : 349-365

Informa Healthcare

Access to resources Recommend Favorite

A deletion in chromosome 11q may predict the response to anthracycline-based chemotherapy in patients with early node-negative breast cancer

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Genetic variants and response to cancer treatments

By Warusavitarne Janindra Stebbing Justin Faiz Omar

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1735-1736

Blackwell Publishing

Access to resources Recommend Favorite